Vertex Pharmaceuticals is marching beyond its cystic fibrosis stronghold with bold steps into pain management and genetic ...

They have recently unveiled their genetically modified creations known as 'woolly mice', mice that have been engineered to exhibit traits reminiscent of the long-extinct woolly mammoth. This article ...

Professor Rashid Bashir and a research team at the Grainger College of Engineering, Urbana, Illinois have developed a novel ...

Zurcher Kantonalbank Zurich Cantonalbank raised its position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 3.0% in ...

Among other functions, the NK cells (natural killers, a type of lymphocyte forming part of the immune system) have the capacity to detect and eliminate cancer cells. But in some cases they cannot ...

Dosing into the eye is an easier prospect than systemic delivery via an infusion or pill, but still represents a step forward in the use of CRISPR as an in vivo therapeutic approach. LCA10 is a ...

CRISPR Therapeutics AG (CRSP) closed at $41.17 in the latest trading session, marking a -1.84% move from the prior day. Biotech is an area that may offer your portfolio growth today and earnings ...

After hours: March 21 at 7:54:03 PM EDT ...

Dutch scientists at Leiden University’s medical centre have discovered the genetic variation which protects against type 1 ...

A team of scientists has unveiled a gene-based diagnostic technology capable of detecting multi-drug-resistant bacteria and ...